Fellow Health, a provider of mail-in semen analysis services, has announced it has delivered over 100,000 patient test results since its product launch in 2020. The company reports its testing volume has increased by more than 50% year-to-date from 2023. The company’s mail-in semen analysis service aims to improve access to male fertility testing, addressing a market where 1 in 6 couples…
Parallel Fluidics, a company developing on-demand microfluidic manufacturing solutions with applications in IVF and other life science fields, has secured $7 million in seed funding. The round was led by J2 Ventures with participation from 8VC and Praxis. The company’s technology is already making waves in the fertility sector. Overture Life, a startup focused on simplifying IVF procedures, is utilizing Parallel Fluidics’…
Scottish technology company iGii has announced a multi-million pound partnership with health monitoring company Prymexa to develop an at-home toolkit for early perimenopause detection. The collaboration aims to address a significant gap in menopause awareness and monitoring, with 60% of women under 40 reporting they don’t feel informed about this life stage. The toolkit will leverage iGii’s proprietary Gii technology, a sustainable…
Every Thursday we send out a curated newsletter on all things femtech and women’s health innovation. This is an excerpt from the latest edition. If you’d like to subscribe, you can do so at the bottom of this page. Highlights Persperity Health raises $1M to develop sweat-based hormone monitoring technology. Vara secures $8.9M to expand AI breast cancer detection platform in emerging markets. Caldera…
You’ve found some of our exclusive Inner Circle Content. This article is only available for our Inner Circle Members. To read on: Sign in to your Inner Circle account to access this content. If you aren’t a member yet and would like to find out more about our Inner Circle program or sign up, click here.
Femasys has announced a strategic partnership with Boston IVF to offer FemaSeed, its FDA-cleared intratubal insemination product, across Boston IVF’s network of nearly 30 fertility centers in the U.S. The collaboration aims to expand access to alternative fertility treatment options before patients progress to more invasive procedures. “We are elated to welcome Boston IVF, a prominent conglomerate in the infertility space, to…
Wisp, a women’s telehealth provider in the U.S., has announced the launch of a new weight care vertical specifically designed to address weight management challenges related to hormonal conditions. The WELL Health Technologies subsidiary, which serves over 1.2 million patients, is expanding its services to include GLP-1 medications and other weight management solutions. The new program specifically targets women struggling with hormonal…
Venture Life Group has announced the acquisition of Health & Her (H&H) for an upfront cash consideration of £7.5 million, with additional payments of up to £2.5 million tied to performance and retention milestones. The acquisition strengthens Venture Life’s position in the rapidly growing hormone health market. Founded in 2018 and headquartered in Cardiff (UK), H&H has established itself as a leading…